Arecor Therapeutics PLC (GB:AREC) has released an update.
Arecor Therapeutics PLC, a biopharmaceutical company, announced the successful placement of 5.8 million new shares and a subscription for 1.16 million shares, raising a total of £6.26 million to advance its therapeutic products. The funds were raised at a 2.7% discount to the previous day’s closing price, involving institutional investors, healthcare funds, and company directors. Additionally, the company is conducting a Retail Offer to raise up to an additional £1 million, with the fundraising contingent on an upcoming General Meeting.
For further insights into GB:AREC stock, check out TipRanks’ Stock Analysis page.
